We investigated the role of intracerebroventricular (ICV) injection of rimonabant (500 ng), a CB 1 antagonist, on lipopolysaccharide ((LPS) 5 mg/kg)-induced pulmonary inflammation in rats in an isolated perfused lung model. There were decreases in pulmonary capillary pressure (Ppc) and increases in the ((Wet-Dry)/Dry lung weight)/ (Ppc) ratio in the ICV-vehicle/LPS group at 4 h. There were decreases in TLR4 pathway markers, such as interleukin receptor-associated kinase-1, IκBα, Raf1 and phospho-SFK (Tyr416) at 30 min and at 4 h increases in IL-6, vascular cell adhesion molecule-1 and myeloperoxidase in lung homogenate. Intracerebroventricular rimonabant attenuated these LPS-induced responses, indicating that ICV rimonabant modulates LPS-initiated pulmonary inflammation.
Introduction
Sepsis has been generally understood as a complex intense systemic inflammatory response due to an infection (Angus et al., 2001; Dellinger et al., 2013; Hotchkiss and Karl, 2003; Van Amersfoort et al., 2003) . The body's acute response to microbial components results in a widespread activation of cells. This causes a plethora of inflammatory mediators such as cytokines (e.g., cytokine storm), chemokines, prostaglandins, lipid mediators and reactive oxygen/nitrogen species to be released (Angus et al., 2001; Dellinger et al., 2013; Hotchkiss and Karl, 2003; Van Amersfoort et al., 2003) . The aforementioned mediators induce systemic vasodilatation and upregulation of adhesion molecules in the endothelium associated with the release, activation and organ sequestration of neutrophils and monocytes (Angus et al., 2001; Dellinger et al., 2013; Hotchkiss and Karl, 2003; Van Amersfoort et al., 2003) . These changes in homeostasis subsequently lead to multiple organ failure such as acute lung injury, myocardial suppression and irreversible hypotension (Angus et al., 2001; Van Amersfoort et al., 2003) .
Lipopolysaccharide (LPS) is used to model the effects of gram negative sepsis (Villanueva et al., 2009; Yilmaz et al., 2008a Yilmaz et al., , 2008b . Although the initiation and progression of LPS hypotension have been explained exclusively as a peripheral event, recent data from our laboratory showed that this effect of LPS can be prevented by (i) inhibiting the vagus nerve, (ii) by blocking neuronal activity in the nucleus of the solitary tract (NTS), (iii) by blocking α-adrenergic receptors in the preoptic area/anterior hypothalamic area (POA) and (iv) by blocking brain cannabinoid 1 receptors (CB 1 ) (Villanueva et al., 2009; Yilmaz et al., 2008a Yilmaz et al., , 2008b . These findings suggest that an inflammatory signal is conveyed from the periphery to the brain and the response to endotoxic shock is mediated through a central mechanism (Villanueva et al., 2009; Yilmaz et al., 2008a Yilmaz et al., , 2008b . Importantly, recent studies show that treatment in the brain with the CB 1 receptor inverse agonist/antagonist, rimonabant, prior to endotoxemia, decreases systemic tumor necrosis factor α (TNF-α) levels and central norepinephrine concentrations within the POA, and prevents endotoxic hypotension (Villanueva et al., 2009) .
Lung inflammation with the resultant acute respiratory distress syndrome (ARDS) is an additional characteristic outcome of severe endotoxemia (Van Amersfoort et al., 2003; Gando et al., 2004) . However, the role of the CB 1 receptors in the brain in the modulation of lung inflammation during endotoxemia has not been studied. Many brain areas, including the hypothalamus, contain CB 1 receptors (Matsuda et al., 1993; Hirasawa et al., 2004; Herkenham et al., 1991) . Furthermore, CB 1 receptors can modulate the autonomic nervous system, and therefore, bidirectional circuits between the periphery and the brain
